10 Nov 2022 , 11:53 AM
Net profit of Lincoln Pharmaceuticals rose 2.95% to Rs 23.71 crore in the quarter ended September 2022 as against Rs 23.03 crore during the previous quarter ended September 2021. Sales rose 10.31% to Rs 140.61 crore in the quarter ended September 2022 as against Rs 127.47 crore during the previous quarter ended September 2021.
Particulars | Quarter Ended | ||
? | Sep. 2022 | Sep. 2021 | % Var. |
Sales | 140.61 | 127.47 | 10 |
OPM % | 20.55 | 22.95 | – |
PBDT | 34.45 | 32.52 | 6 |
PBT | 32.03 | 30.53 | 5 |
NP | 23.71 | 23.03 | 3 |
Powered by Capital Market – Live News
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.